Status:
COMPLETED
Metabolic, Functional and Nutritional Responses to Weight Cycling in Athletes: The WAVE Study
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Laboratoire AME2P
Université de Fribourg, Department of Endocrinology, Metabolism and Cardiovascular System
Conditions:
Athletes
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Many elite athletes are submitted to frequent rapid weight loss periods to meet their competition weight category and then experience weight cycling (lowing and gaining weight regularly). This weight ...
Detailed Description
After an inclusion visit to ensure the eligibility of athletes to complete the entire study, each subject will perform 3 experimental sessions of 2 visits each : i) two visits during a period of maint...
Eligibility Criteria
Inclusion
- Subjects aged 18 to 35 (inclusive),
- exercising at least 4 sessions of endurance or weight-based sporting activities per week for a performance objective,
- having variations of at least 5% of their weight body during the last 3 sporting seasons (a sporting season corresponds to a year during which alternates the periods of training, recovery and participation in official competitions).
- Subject capable of providing informed consent to participate
- Subject with a social security insurance.
Exclusion
- Medical or surgical history deemed by the investigator to be incompatible with the study.
- Presence of chronic pathology.
- Disorders of eating behavior.
- Subjects born very prematurely defined as a pregnancy inferior to 28 weeks.
- Subjects having used a treatment for a small stature (eg growth hormone).
- For women: irregular menstruation (changes in menstrual cycles ≥ 6 days).
- Sports subjects with a stable weight during the last three sporting seasons (weight variation \<5%).
- Take medication that can change body temperature.
- Pregnant or lactating women.
- Subjects with gastrointestinal complications and / or contraindications to ingestion of the capsule (eg diverticulosis, inflammatory bowel disease, gastrointestinal surgery ...).
- Subjects needing MRI during ingestion of the capsule or having a pacemaker or other implanted electro-medical device.
- Person under guardianship or not subject to a social security scheme.
- Refusal to sign the information and consent leaflet.
- Refusal of participation
Key Trial Info
Start Date :
May 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04107545
Start Date
May 3 2021
End Date
December 12 2023
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont Ferrand
Clermont-Ferrand, France, 63003